March 13, 2024 · Form 4 insider transaction
MURPHY ANDREW J bought 20,000 shares of Regeneron Pharmaceuticals, Inc. at $399.66 per share, a transaction worth $7.99M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 9, 2023.